Back to search

Article

A combined miR-34a and arsenic trioxide nanodrug delivery system for synergistic inhibition of HCC progression after microwave ablation

2021-06-14

Abstract excerpt

<h4>Background: </h4> Microwave ablation (MWA) has become an alternative treatment for unresectable surgery for hepatocellular carcinoma (HCC), but it still faces the risk of recurrence and metastasis after treatment. Recent studies have found that miR-34a presents decreased gene expression in residual tumours after ablation therapy and can increase the therapeutic effect of arsenic trioxide on HCC, which brings n...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8cb493db-570b-59eb-a37e-f7bbf05970cd
DOI
10.21203/rs.3.rs-609280/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A combined miR-34a and arsenic trioxide nanodrug delivery system for synergistic inhibition of HCC progression after microwave ablationDOI 10.21203/rs.3.rs-609280/v1
Select a neighboring publication to make it the new centre.